EUDA Health director files Form 3

EUDA Health Holdings Ltd director Lew Chern Yong has filed a Form 3, which records his status as an insider of the company.

Rhea-AI Filing Summary

EUDA Health Holdings Ltd director Lew Chern Yong has filed a Form 3, which records his status as an insider of the company. The provided data does not list any equity transactions or derivative positions, and the transaction summary shows no buys, sells, or other reportable trades.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Lew Chern Yong’s Form 3 filing for EUDA (EUDA) show?

The Form 3 for Lew Chern Yong at EUDA Health Holdings Ltd identifies him as a director. The provided data shows no reported buy, sell, or derivative transactions and no derivative positions in the transaction and derivative summaries.

Are there any insider share purchases or sales in this EUDA Form 3?

No insider purchases or sales are listed in this EUDA Health Holdings Ltd Form 3. The transaction summary reports zero buys, zero sells, and no derivative exercises or other reportable trades for director Lew Chern Yong in the provided data.

Does the EUDA Lew Chern Yong Form 3 disclose derivative securities?

The filing data for EUDA Health Holdings Ltd shows an empty derivative summary for director Lew Chern Yong. That means no options, warrants, or other derivative securities are detailed in the excerpted Form 3 information provided here.

What does the transaction summary indicate in EUDA’s Form 3?

The transaction summary for EUDA Health Holdings Ltd director Lew Chern Yong shows zero buy, sell, exercise, gift, tax-withholding, or restructuring events, and a neutral net buy/sell direction, indicating no reportable trading activity in this dataset.

Who is the reporting person in this EUDA Health Holdings Form 3?

The reporting person is Lew Chern Yong, identified as a director of EUDA Health Holdings Ltd. He is not listed as an officer or ten-percent owner in the provided insider filing data for this Form 3 submission.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:16 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lew Chern Yong

(Last) (First) (Middle)

60 KAKI BUKIT PLACE, #03-01

(Street)

EUNOS TECHPARK 415979

(City) (State) (Zip)

SINGAPORE

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
EUDA Health Holdings Ltd [ EUDA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Chern Yong Lew	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)